Azithromycin covid prophylaxis

Jul 21, 2020 · Azithromycin has been proposed as a drug to treat COVID-19 infection, although this drug has torsadogenic potential which is cause for concern, especially if concomitantly administered with hydroxychloroquine/chloroquine We recommend formal clinical trials of azithromycin in its prepackaged form at the first sign of COVID-19 infection in adults and children, using an initial adult dose of 500 mg followed by 250 mg per day for 4 days, a total cumulative dose of 1. In nursing homes, antibiotic use spiked alongside surges of COVID-19 cases but remains lower overall

2024-03-29
    Karel knize lima
  1. The ProPac-COVID trial evaluates whether combination therapy with
  2. Conclusion: Although efficacy could not be assessed due to premature
  3. In our
  4. 1, 2 The association of
  5. S
  6. AIIa